CELZ

$0.00

(

0.00%

)
Quote details

stock

Creative Medical Technology Holdings Inc

NASDAQ | CELZ

3.63

USD

$0.00

(

0.00%

)

At Close (As of Sep 17, 2025)

$9.57M

Market Cap

-

P/E Ratio

-3.13

EPS

$6.90

52 Week High

$1.69

52 Week Low

HEALTHCARE

Sector

CELZ Chart

Recent Chart
Price Action

CELZ Technicals

Tags:

CELZ Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $6.6K
Total Revenue $11K
Cost Of Revenue $4.4K
Costof Goods And Services Sold $4.4K
Operating Income -$5.7M
Selling General And Administrative $3.2M
Research And Development $2.4M
Operating Expenses $5.8M
Investment Income Net -
Net Interest Income $250K
Interest Income $250K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $110K
Income Before Tax -$5.5M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$5.5M
Comprehensive Income Net Of Tax -
Ebit -$5.7M
Ebitda -$5.6M
Net Income -$5.5M

Revenue & Profitability

Earnings Performance

CELZ Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $6.7M
Total Current Assets $6.1M
Cash And Cash Equivalents At Carrying Value $5.9M
Cash And Short Term Investments $5.9M
Inventory $2.2K
Current Net Receivables -
Total Non Current Assets $534K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $531K
Intangible Assets Excluding Goodwill $531K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $0
Other Current Assets $193K
Other Non Current Assets -
Total Liabilities $328K
Total Current Liabilities $328K
Current Accounts Payable $274K
Deferred Revenue -
Current Debt -
Short Term Debt $14K
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $14K
Other Current Liabilities $40K
Other Non Current Liabilities -
Total Shareholder Equity $6.3M
Treasury Stock -
Retained Earnings -$65M
Common Stock $1.7K
Common Stock Shares Outstanding $1.5M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$5.3M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $110K
Capital Expenditures $200K
Change In Receivables -
Change In Inventory $4.4K
Profit Loss -
Cashflow From Investment $6.3M
Cashflow From Financing $1.5M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$175K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$5.5M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $6.6K
Total Revenue $11K
Cost Of Revenue $4.4K
Costof Goods And Services Sold $4.4K
Operating Income -$5.7M
Selling General And Administrative $3.2M
Research And Development $2.4M
Operating Expenses $5.8M
Investment Income Net -
Net Interest Income $250K
Interest Income $250K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $110K
Income Before Tax -$5.5M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$5.5M
Comprehensive Income Net Of Tax -
Ebit -$5.7M
Ebitda -$5.6M
Net Income -$5.5M

CELZ News

CELZ Profile

Creative Medical Technology Holdings Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Creative Medical Technology Holdings, Inc. (CELZ) is a pioneering biotechnology firm based in Phoenix, Arizona, specializing in innovative therapies through adult stem cell treatments. Focusing on key medical fields including immunology, urology, orthopedics, and neurology, the company aims to address unmet medical needs and improve patient outcomes. With a commitment to advancing regenerative medicine, CELZ is positioned at the forefront of developing novel treatments that leverage the inherent potential of stem cells.

ATCH
+87.36%
$1.62
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
NFE
+8.00%
$2.16
SPRC
+142.93%
$4.47
NIO
+6.05%
$7.44
QBTS
+19.44%
$22.66
GRAB
-3.48%
$6.10
TSLA
+1.00%
$425.86
AAL
+0.84%
$12.51
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NUAI
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
SOFI
-1.02%
$27.14
RGTI
+9.92%
$21.98
TPIC
-45.91%
$0.12
PLTR
-1.13%
$168.33
DNN
+1.60%
$2.54
AXDX
-61.36%
$0.03
ADAP
-1.22%
$0.08
BBD
+2.95%
$3.30
PGRE
-11.43%
$6.54
F
+0.52%
$11.67
INTC
-1.46%
$24.90
BMNR
+1.98%
$57.04
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
JOBY
-1.59%
$14.16
MULN
-12.58%
$0.06
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
KDLY
-4.66%
$1.43
NAKA
-4.66%
$1.43
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.95%
$92.98
AMZN
-1.03%
$231.62
AIRE
-1.57%
$1.25
ACHR
-1.20%
$9.00
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
IONQ
+4.97%
$65.36
ABEV
0.00%
$2.36
LDI
+2.70%
$4.55
RIOT
+0.82%
$17.66
BINI
-6.96%
$0.06
RMBL
+60.50%
$3.21
WULF
+3.74%
$11.35
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
OPI
-31.80%
$0.56
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
HOOD
+1.07%
$118.64
DVLT
-22.98%
$0.34
NOK
+1.84%
$4.69
QUBT
+4.97%
$17.71
CIFR
+7.55%
$12.38
GOOGL
-0.64%
$249.53
IREN
+3.97%
$37.90
NWTN
+12.58%
$1.70
CWD
+19.05%
$7.56
ATYR
-5.09%
$1.02
JD
+1.52%
$35.24
FAAS
-6.04%
$0.09
ITUB
+1.82%
$7.27
INFY
+3.60%
$17.67
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
KEY
+0.42%
$18.71
BABA
+2.39%
$166.09
BAC
+1.41%
$51.37
BTE
-2.49%
$2.54
WLGS
-5.57%
$0.04
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
T
-0.97%
$29.33
HBAN
+0.63%
$17.54
JBLU
0.00%
$5.07
RAYA
-4.69%
$0.04
HIMS
-1.06%
$50.35
CAN
+0.23%
$0.80
ETWO
0.00%
$3.30
PEB
+2.03%
$11.79
GDXD
+2.45%
$1.25
ATCH
+87.36%
$1.62
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
NFE
+8.00%
$2.16
SPRC
+142.93%
$4.47
NIO
+6.05%
$7.44
QBTS
+19.44%
$22.66
GRAB
-3.48%
$6.10
TSLA
+1.00%
$425.86
AAL
+0.84%
$12.51
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NUAI
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
SOFI
-1.02%
$27.14
RGTI
+9.92%
$21.98
TPIC
-45.91%
$0.12
PLTR
-1.13%
$168.33
DNN
+1.60%
$2.54
AXDX
-61.36%
$0.03
ADAP
-1.22%
$0.08
BBD
+2.95%
$3.30
PGRE
-11.43%
$6.54
F
+0.52%
$11.67
INTC
-1.46%
$24.90
BMNR
+1.98%
$57.04
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
JOBY
-1.59%
$14.16
MULN
-12.58%
$0.06
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
KDLY
-4.66%
$1.43
NAKA
-4.66%
$1.43
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.95%
$92.98
AMZN
-1.03%
$231.62
AIRE
-1.57%
$1.25
ACHR
-1.20%
$9.00
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
IONQ
+4.97%
$65.36
ABEV
0.00%
$2.36
LDI
+2.70%
$4.55
RIOT
+0.82%
$17.66
BINI
-6.96%
$0.06
RMBL
+60.50%
$3.21
WULF
+3.74%
$11.35
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
OPI
-31.80%
$0.56
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
HOOD
+1.07%
$118.64
DVLT
-22.98%
$0.34
NOK
+1.84%
$4.69
QUBT
+4.97%
$17.71
CIFR
+7.55%
$12.38
GOOGL
-0.64%
$249.53
IREN
+3.97%
$37.90
NWTN
+12.58%
$1.70
CWD
+19.05%
$7.56
ATYR
-5.09%
$1.02
JD
+1.52%
$35.24
FAAS
-6.04%
$0.09
ITUB
+1.82%
$7.27
INFY
+3.60%
$17.67
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
KEY
+0.42%
$18.71
BABA
+2.39%
$166.09
BAC
+1.41%
$51.37
BTE
-2.49%
$2.54
WLGS
-5.57%
$0.04
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
T
-0.97%
$29.33
HBAN
+0.63%
$17.54
JBLU
0.00%
$5.07
RAYA
-4.69%
$0.04
HIMS
-1.06%
$50.35
CAN
+0.23%
$0.80
ETWO
0.00%
$3.30
PEB
+2.03%
$11.79
GDXD
+2.45%
$1.25

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.